Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives

US7691855B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Pascal Furet · Basel, CH
• Patricia Imbach · Kaiseraugst, CH
• Timothy Ramsey · Sparta, US
• Achim Schlapbach · Bad Kötzting, DE
• Dieter Scholz · Wien, AT
• Giorgio Caravatti · Allschwil, CH

Key dates

• Filing date: Jul 8, 2003
• Grant date: Apr 6, 2010
• Expiry date: Nov 29, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives—alone or in combination with one or more other pharmaceutically active compounds—for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumor.